TP53 and cancer: DHEA can also downregulate the WNT/beta-catenin pathway to inhibit cancer stem cells and sensitize irinotecan in the head and neck cancer (Li et al., 2022), as well as upregulate the p53 pathway in the breast cancer (Yang et al., 2016).